How Medicaid cuts could impact a family affected by SCID
Lunch & Learn: Understanding genetic variants in APDS
Update: What RSV preventatives mean for those with PI
Genentech
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Still have vaccine questions?
Join the Immune Deficiency Foundation online October 29, 2026, at 7:00 p.m. ET for "Decoding PI: Vaccines and the PI community" with Michael Keller, M.D., Children's National Hospital, and Kelli Williams M.D., MPH, Medical University of South Carolina.
Rocket scientist with CVID encourages others to pursue their passion
Jorey's monthly wrap-up: May 2025
Consider increasing Ig therapy for breakthrough infections
Lunch and Learn: Understanding genetic variants in APDS

